Raymond James reiterates Strong Buy on Dime Community stock By Investing.com

Raymond James reiterated a Strong Buy on Dime Community Bancshares with a $46 price target after solid Q1 2026 results, citing continued commercial and industrial growth, incremental net interest margin expansion, and improved efficiency ratio, down 480 bps year over year. The firm expects NIM expansion to accelerate in 2H 2026 and models EPS growth of 30% in 2026 and 33% in 2027. The article is more notable for analyst commentary than immediate market-moving news, though it also flagged a weaker technical backdrop for bank stocks.

Analysis

DCOM looks less like a simple quality-re-rating and more like a self-help earnings inflection with optionality from deposit mix and operating leverage. The key second-order effect is that strong C&I momentum plus back-book repricing should widen the spread gap versus slower-growing regional peers exactly when the market is rewarding balance-sheet simplicity and visible EPS acceleration. That creates a path for multiple expansion if management can keep deposit beta contained while the new banker hires convert into production rather than just expense drag.

The more interesting competitive angle is that Raymond James’ shift toward SFBS suggests the market is starting to differentiate winners within the regional cohort based on near-term NIM torque and loan growth visibility, not just asset quality. If that rotation sticks, capital could flow away from “steady but slow” banks into names with cleaner repricing upside and better fee/expense leverage, while the KBW technical break can keep passive and factor-driven selling pressure on the whole group for weeks even if fundamentals remain constructive.

The main risk is timing: the earnings step-up thesis is a second-half story, so the stock can underperform for 1–2 quarters if rates stabilize, deposit costs re-accelerate, or the hiring spree dilutes efficiency before revenue contribution shows up. The consensus appears to be underestimating how much of the upside is already in the stock after a 6-month rerating; the more likely miss is not on earnings magnitude, but on how much multiple expansion is left before the market demands proof. That makes this a better relative-value long than a blind outright chase.

The contrarian view is that regional-bank fundamentals are improving while the tape remains technically broken, which often creates the best entry points for patient capital. If DCOM executes, the stock can de-risk into H2 as earnings revisions catch up; if not, the downside should be buffered by the valuation floor relative to its growth profile. The asymmetry is strongest if we can own DCOM against a weaker beta regional basket rather than as a standalone momentum name.

Key Decisions for Investors

• Go long DCOM on a 1-3 month horizon, but only on weakness or consolidation; target a 10-15% upside if H2 NIM expansion starts to show up, with a stop if deposit costs or efficiency metrics deteriorate two quarters in a row.
• Pair trade: long DCOM / short KRE for 6-12 weeks to isolate idiosyncratic earnings torque from the broader bank technical drawdown; this should work if relative EPS revisions continue to diverge.
• Rotate partial exposure from slower-growth regional banks into SFBS on a 3-6 month horizon as a cleaner beneficiary of NIM expansion and loan growth, using DCOM as the more leveraged self-help story and SFBS as the steadier compounder.
• Avoid chasing DCOM after sharp up-days; instead sell put spreads or wait for pullbacks around broad bank-market weakness, since the stock’s near-term path is likely dictated more by sector flows than by fundamentals.
• If owning outright, consider pairing DCOM equity with an out-of-the-money downside hedge on KRE for the next 1-2 quarters to protect against another technical leg lower in the regional-bank index.